Market Cap (In INR)
9.5 Billion
Revenue (In INR)
5.75 Billion
Net Income (In INR)
559.56 Million
Avg. Volume
37.77 Thousand
- Currency
- INR
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 122.1-325.0
- PE
- -
- EPS
- -
- Beta Value
- 0.53
- ISIN
- INE107F01022
- CUSIP
- -
- CIK
- -
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Mr. Pradeep Patni
- Employee Count
- -
- Website
- https://www.wanbury.com
- Ipo Date
- Details
- Wanbury Limited manufactures and sells formulations and active pharmaceutical ingredients (API) in India. The company offers formulations for gynecology, orthopedics, heamatinics, anti-diabetic, nutraceuticals, gastro intestinal, stroke surgery, antibiotics, cough and cold solutions, anti-inflammatory, analgesics, and general practitioner. It also provides API products for anti-diabetic, anti-analgesic, anti-depressant, anti-histaminic, anti-inflammatory, anti-arthritis, anti-thrombotic, anti-epileptic, and anti-hypertensive therapeutic areas. Wanbury Limited also exports its products. The company was formerly known as Pearl Organics Limited and changed its name to Wanbury Limited in 2004. Wanbury Limited was incorporated in 1988 and is headquartered in Navi Mumbai, India.
More Stocks
-
0QQ4
-
CRNX
-
CHOLAHLDNGCholamandalam Financial Holdings Limited
CHOLAHLDNG
-
BASANTGLBasant Agro Tech (India) Limited
BASANTGL
-
OBL
-
002885
-
AMBC
-
UPST